These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10073054)

  • 41. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
    Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vaccination and immunization in healthcare workers, towards specific infections: measles, varicella, rubella and mumps. The experience in a hospital in Lombardy].
    Cologni L; Belotti L; Bacis M; Bigoni F; Grigis A; Passerini C; Locati F; Mosconi G
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):413-4. PubMed ID: 18409751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997.
    Sullivan EM; Burgess MA; Forrest JM
    Commun Dis Intell; 1999 Aug; 23(8):209-14. PubMed ID: 10497832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What are the causes of suspected cases of measles?
    Commun Dis Rep CDR Wkly; 1997 Feb; 7(6):45. PubMed ID: 9046127
    [No Abstract]   [Full Text] [Related]  

  • 45. Measles immunity in HIV-infected children.
    Walter EB; Katz SL; Bellini WJ
    Pediatr AIDS HIV Infect; 1994 Oct; 5(5):300-4. PubMed ID: 11361371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measles, mumps, and rubella: prevention.
    Booy R; Sengupta N; Bedford H; Elliman D
    Clin Evid; 2006 Jun; (15):448-68. PubMed ID: 16973018
    [No Abstract]   [Full Text] [Related]  

  • 47. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
    Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E
    Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measles, mumps, rubella vaccine: through a glass, darkly.
    Wakefield AJ; Montgomery SM
    Adverse Drug React Toxicol Rev; 2000 Dec; 19(4):265-83; discussion 284-92. PubMed ID: 11212459
    [No Abstract]   [Full Text] [Related]  

  • 49. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
    Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "KITS" for improved immunization of Kauai children.
    Manea SJ
    Hawaii Med J; 1997 May; 56(5):121-3, 128. PubMed ID: 9188222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical safety issues of measles, mumps and rubella vaccines.
    Afzal MA; Minor PD; Schild GC
    Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autism, viral infection and measles-mumps-rubella vaccination.
    Wakefield AJ; Montgomery SM
    Isr Med Assoc J; 1999 Nov; 1(3):183-7. PubMed ID: 10731332
    [No Abstract]   [Full Text] [Related]  

  • 54. Understanding autism.
    Cowley G
    Newsweek; 2000 Jul; 136(5):46-54. PubMed ID: 11009739
    [No Abstract]   [Full Text] [Related]  

  • 55. Recommendations for using MMR vaccine in children allergic to egg should be consistent.
    Andrew F; Riordan I
    Arch Dis Child; 2000 Sep; 83(3):276. PubMed ID: 10991756
    [No Abstract]   [Full Text] [Related]  

  • 56. Experience of a specialist service for advice on childhood immunisation.
    Newport MJ; Conway SP
    J Infect; 1993 May; 26(3):295-300. PubMed ID: 8505563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The real horrors.
    Cresswell J
    Community Nurse; 1999 Oct; 5(9):10. PubMed ID: 10732568
    [No Abstract]   [Full Text] [Related]  

  • 58. Is confidence in immunisation declining?
    Mansoor O; Sarfati D; Durham G
    N Z Med J; 1998 Aug; 111(1071):300. PubMed ID: 9760957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A retrospective cohort study of risk factors for missing preschool booster immunisation.
    Evans MR; Thomas DR
    Arch Dis Child; 1998 Aug; 79(2):141-4. PubMed ID: 9797595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interference of immune globulin with measles and rubella immunization.
    Eur J Pediatr; 1993 Jun; 152(6):536. PubMed ID: 8335028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.